Dhofar Insurance Company SAOG (MSM:DICS)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions OMR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	24	25	27	22	20	16
Market Cap Growth	-2.73%	-8.74%	24.15%	12.28%	18.90%	-6.29%
Enterprise Value	15	9	19	14	20	15
PE Ratio	5.30	5.93	4.41	5.62	7.63	4.26
PS Ratio	0.27	0.28	0.35	0.32	0.70	0.62
PB Ratio	-	0.63	0.77	0.74	0.72	0.64
P/FCF Ratio	-	3.52	3.79	2.36	-	3.54
P/OCF Ratio	-	3.46	3.66	2.35	-	3.50
EV/Sales Ratio	0.17	0.10	0.25	0.21	0.72	0.55
EV/EBITDA Ratio	2.90	1.42	2.64	2.97	5.21	2.73
EV/EBIT Ratio	3.02	1.47	2.70	3.07	5.47	2.79
EV/FCF Ratio	-	1.29	2.65	1.53	-	3.15
Debt / Equity Ratio	-	-	-	0.10	-	-
Debt / EBITDA Ratio	-	-	-	0.63	-	-
Debt / FCF Ratio	-	-	-	0.32	-	-
Quick Ratio	-	6.13	10.02	5.55	0.17	0.27
Current Ratio	-	22.35	35.79	22.24	0.86	0.86
Asset Turnover	-	0.65	0.61	0.54	0.21	0.19
Return on Equity (ROE)	-	11.24%	19.12%	13.79%	9.71%	16.23%
Return on Assets (ROA)	-	2.85%	3.47%	2.26%	1.71%	2.33%
Return on Capital (ROIC)	-	10.40%	13.03%	9.69%	8.73%	12.46%
Earnings Yield	18.43%	16.85%	22.70%	17.78%	13.10%	23.49%
Earnings Yield	18.43%	16.85%	22.70%	17.78%	13.10%	23.49%
FCF Yield	-	28.39%	26.39%	42.32%	-30.66%	28.25%
Dividend Yield	7.32%	7.31%	6.93%	8.84%	10.27%	8.66%
Payout Ratio	-	39.17%	25.47%	38.53%	39.14%	-
Buyback Yield / Dilution	11.14%	12.62%	4.11%	7.00%	-42.79%	-
Total Shareholder Return	18.46%	19.93%	11.04%	15.84%	-32.52%	8.66%

Updated Mar 2, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.